- 31 Jan 2022
- 1 min read
It’s time to have a clear regulatory framework for emergency approval of drugs in India
This opinion was published in Economic Times on January 31, 2022.
About the Authors
Shreya is a Senior Resident Fellow working in the area of Health and Education. She is currently working on research projects related to public health, patient rights and inclusive education. Her areas of interest include Public Health, Right to Education, Constitutional law, Cyber law, and the intersection of Health and Technology. Shreya graduated with a B.A. LL.B. (Hons.) from Hidayatullah National Law University, Raipur in 2018. She has been published in newspapers and websites like The Hindu and The Wire. She has co-authored the Centre for Civil Society’s ‘Compendium of laws to be repealed in Chhattisgarh’. In collaboration with the Centre for Communication Governance (CCG), she submitted an academic paper to MEITY on ‘Non-Consensual Obscene Content and Indian Law’. Prior to joining Vidhi, she has interned with policy organisations like CCG and the Land Rights Initiative at the Centre for Policy Research, in the Chambers of Senior Advocate Prashant Bhushan, and with law firms like Karanjawala & Co and Samvaad Partners.
How Rajasthan Can Make Right to Health a Reality
Two lawyers parse Rajasthan’s Right to Health bill and argue that the state must define ‘emergency’ and create a reimbursement fund
18 Pharma Companies Lose Licenses: Why It Won’t Change Much For Drug Regulation
Privacy & Cookies Policy